Boundless Bio BOLD
NASDAQ BOLD
$2.97 +0.07 (+2.59%)
As of: Aug 21, 2026 · 10:40 AM EDT

Boundless Bio (BOLD) Treasury Shares (2023 - 2024)

Boundless Bio (BOLD) posted quarterly Treasury Shares of $287.4 million for Q1 2024, up 98.8% year-over-year from $144.6 million in Q2 2023, and little changed quarter-over-quarter from $287.4 million in Q4 2023.

Boundless Bio (BOLD) Treasury Shares (2023 - 2024) Analysis & Trends

Boundless Bio (BOLD) has reported Treasury Shares for 2 consecutive years, with $287.4 million the latest figure, recorded in Q1 2024.

  • In Q1 2024, Treasury Shares rose 98.8% year-over-year to $287.4 million; the TTM figure through Mar 2024 stood at $287.4 million (up 98.8% YoY), while the FY2023 annual figure was $287.4 million, changed N/A from the prior year.
  • Treasury Shares was little changed at $287.4 million in Q1 2024 per BOLD's latest filing, from $287.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $287.4 million in Q4 2023 and bottomed at $144.6 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 140.29 Bn 132.43 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.58 Bn 78.58 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 65.26 Bn 60.08 Bn 1.37 Bn -
4 Moderna 61.87 Bn 56.73 Bn 52.00 Mn -
5 BeOne Medicines 42.18 Bn 37.08 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.51 Bn 28.20 Bn 992.69 Mn -
7 BioNTech SE 28.90 Bn 10.51 Bn 668.28 Mn 8.96 Mn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -
9 Royalty Pharma 27.24 Bn 26.41 Bn - 2.72 Mn
10 Boundless Bio 66.79 Mn 66.79 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 287.45 Mn
Mar 31, 2024 287.45 Mn
Dec 31, 2023 287.45 Mn
Dec 31, 2023 287.45 Mn
Sep 30, 2023 287.45 Mn
Sep 30, 2023 287.45 Mn
Jun 30, 2023 287.45 Mn
Jun 30, 2023 287.45 Mn
Mar 31, 2023 144.59 Mn
Mar 31, 2023 144.59 Mn